Horizon Therapeutics gets good news for flagship drug while advancing MoCo R&D hub, Amgen deal


The company is among multiple biotechs to make big moves in the D.C. area in recent days.

Previous Research Medical Center appoints a new CEO
Next New dean talks vision for UAB Marnix E. Heersink School of Medicine